Myomar Molecular
Halifax · Founded 2021
About Myomar Molecular
Myomar Molecular is developing a diagnostic tool to identify early stages of muscle atrophy. this technology will be used by physiotherapists and medical doctors to access therapy approaches, reduce hospitalization time, and analyze recovery progress.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.3M
- Funding stage: Seed
- Last round: Pre-Seed (Mar 2024)
- Website: https://myomarmolecular.ca
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/myomar-molecular-111243 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.